Search Results - "Polyzos N"

Mild vs. intense ovarian stimulation in POSEIDON Group 2 suboptimal responders. A non-inferiority randomized controlled trial.

Authors: Polyzos, N. P. Garcia-Martinez, S. Ignacio, R. et al.

Source: Human Reproduction. 2026 Supplement, Vol. 41, pi642-i642. 1/2p.

This result is not displayed to guests.
Login for full access.

The role of appendectomy as part of the treatment of a mucinous borderline ovarian tumor.

Authors: Cosyns, S. Polyzos, N. P. Carprieaux, M. et al.

Source: European Journal of Gynaecological Oncology. 2016, Vol. 37 Issue 2, p167-170. 4p.

Application and assessment of a financial distress projection model in private general clinics.

Authors: KARAKOLIAS, S. POLYZOS, N.

Source: Archives of Hellenic Medicine / Arheia Ellenikes Iatrikes. Jul-Aug2015, Vol. 32 Issue 4, p475-483. 9p.

A three-year Performance Evaluation of the NHS Hospitals in Greece.

Authors: Polyzos, N.¹

Source: Hippokratia. 2012, Vol. 16 Issue 4, p350-355. 6p. 4 Charts, 2 Graphs.

SAY NO to mild ovarian stimulation for all poor responders: it is time to realize that not all poor responders are the same.

Authors: Polyzos, N P Popovic-Todorovic, B

Source: Human Reproduction. Sep2020, Vol. 35 Issue 9, p1964-1971. 8p.

This result is not displayed to guests.
Login for full access.

The biopsy-to-vitrification interval does not compromise live birth rates. An analysis of >2000 euploid blastocyst transfers.

Authors: Mateo cuadros, S. Rodriguez, I. Polyzos, N. P. et al.

Source: Human Reproduction. 2026 Supplement, Vol. 41, pi387-i388. 2p.

What is the optimal duration of progesterone administration before transferring a vitrified-warmed cleavage stage embryo? A randomized controlled trial.

Authors: van de Vijver, A. Polyzos, N. P. Van Landuyt, L. et al.

Source: Human Reproduction. May2016, Vol. 31 Issue 5, p1097-1104. 8p. 1 Diagram, 5 Charts, 1 Graph.

A prospective randomized controlled trial investigating the effect of artificial shrinkage (collapse) on the implantation potential of vitrified blastocysts.

Authors: Van Landuyt, L. Polyzos, N. P. De Munck, N. et al.

Source: Human Reproduction. Nov2015, Vol. 30 Issue 11, p2509-2518. 10p. 1 Diagram, 4 Charts.

Sub-optimal responders following controlled ovarian stimulation: an overlooked group?

Authors: Polyzos, N. P. Sunkara, S. K.

Source: Health Policy & Planning. Sep2015, Vol. 30 Issue 9, p2005-2008. 4p.

This result is not displayed to guests.
Login for full access.

Cryopreserved embryo transfer in an artificial cycle: is GnRH agonist down-regulation necessary?

Authors: van de Vijver, A. Polyzos, N. P. Van Landuyt, L. et al.

Source: Reproductive BioMedicine Online (Elsevier Science). Nov2014, Vol. 29 Issue 5, p588-594. 7p.

Administration of corifollitropin alfa on Day 2 versus Day 4 of the cycle in a GnRH antagonist protocol: a randomized controlled pilot study.

Authors: Blockeel, C Polyzos, N P Derksen, L et al.

Source: Human Reproduction. Jul2014, Vol. 29 Issue 7, p1500-1507. 8p.

Addition of highly purified HMG after corifollitropin alfa in antagonist-treated poor ovarian responders: a pilot study.

Authors: Polyzos, N P De Vos, M Corona, R et al.

Source: Human Reproduction. May2013, Vol. 28 Issue 5, p1254-1260. 7p.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

DuoStim: are we really comparing follicular phase with luteal phase stimulations?

Authors: Racca, A Polyzos, N P

Source: Human Reproduction. Jun2021, Vol. 36 Issue 6, p1722-1723. 2p.

Reply: The evergreen conundrum of poor response: is the dose really irrelevant?

Authors: Polyzos, N P Todorovic, B Popovic Popovic Todorovic, B

Source: Human Reproduction. Apr2021, Vol. 36 Issue 4, p1157-1158. 2p.

This result is not displayed to guests.
Login for full access.